Lipoprotein(a) concentrations associate with coronary artery disease severity in single-center observational cohort of 238 adultsHigher Lipoprotein(a) Linked to Worse Heart Disease Severity

Frontiers in Medicine Published April 23, 2026 DOI ↗ Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Recognize that Lp(a) levels increased stepwise with CAD severity, though causation is not established.

This single-center observational cohort study evaluated 238 adults (mean age 65.1 ± 0.6 years; 60% male) referred for elective coronary angiography in Kazakhstan. The primary exposure involved Lipoprotein(a) [Lp(a)] concentrations assessed via fasting venous blood samples. The study aimed to determine the relationship between Lp(a) concentrations and coronary artery disease severity.

Participants were categorized into coronary artery disease (CAD) severity groups including no significant stenosis, 1-vessel, 2-vessel, and ≥3-vessel disease. Prevalence of significant CAD was 185 patients (78%), while 53 (22%) had no obstructive disease. Lp(a) levels increased stepwise with CAD severity: 36.5 ± 9.4 nmol/L (no stenosis), 45.3 ± 9.0 nmol/L (1-vessel), 76.7 ± 14.6 nmol/L (2-vessel), and 97.2 ± 15.8 nmol/L (≥3-vessel disease).

Safety data regarding adverse events, serious adverse events, or discontinuations were not reported in this publication. Key limitations include the single-center setting which may limit generalizability and the observational design where association does not imply causation. Furthermore, the abstract text was truncated at the p-value, preventing full statistical assessment of significance. The practice relevance involves determining an Lp(a) threshold associated with obstructive coronary disease in Central Asia. Clinicians should interpret these findings cautiously given the study design constraints and incomplete statistical reporting in this region.

This observational study examined blood samples from 238 adults in Kazakhstan to check heart artery blockages. Because it was a single-center report, the findings might not apply to everyone. They measured a specific type of cholesterol called lipoprotein(a) to see how it related to disease severity.

The results showed that people with more severe heart disease had higher levels of this substance. Those with no blockages had the lowest levels, while those with severe disease had the highest.

The data came from an abstract that was cut off before full statistical details were shared. This means we cannot say for sure that high lipoprotein(a) causes worse heart disease. It simply shows a connection between the two in this specific group of patients.

Patients should discuss their heart health with a doctor rather than relying on this single report. More research is needed to understand if lowering these levels helps prevent heart problems. This work helps identify potential thresholds for risk in Central Asia. The average age of participants was about 65 years old, and most were men.

What this means for you:

Higher Lp(a) levels linked to worse heart artery blockages, but this study cannot prove cause and effect.

Study Details

Study typeCohort

EvidenceLevel 3

PublishedApr 2026

View Original Abstract ↓

BackgroundLipoprotein(a) [Lp(a)] is an established, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), but population-specific thresholds for cardiovascular risk remain uncertain. Data from Central Asia are particularly limited. We aimed to evaluate the relationship between Lp(a) concentrations and coronary artery disease (CAD) severity in a Kazakhstani cohort and to determine an Lp(a) threshold associated with obstructive coronary disease.MethodsIn this single-center observational study, 238 adults (mean age 65.1 ± 0.6 years; 60% male) referred for elective coronary angiography were enrolled. Fasting venous blood samples were obtained for a full lipid panel and Lp(a) assessment. Lp(a) levels were quantified in nmol/L using an immunoturbidimetric method. CAD severity was categorized as no significant stenosis, 1-vessel, 2-vessel, or ≥3-vessel disease. Between-group comparisons were performed using t-tests and ANOVA. Receiver operating characteristic (ROC) analysis identified an optimal Lp(a) cut-off for predicting significant CAD (≥50% stenosis in ≥1 vessel), with the Youden index determining the threshold.ResultsSignificant CAD was present in 185 patients (78%), while 53 (22%) had no obstructive disease. Lp(a) levels increased stepwise with CAD severity: 36.5 ± 9.4 nmol/L (no stenosis), 45.3 ± 9.0 nmol/L (1-vessel), 76.7 ± 14.6 nmol/L (2-vessel), and 97.2 ± 15.8 nmol/L (≥3-vessel disease) (p 

Lipoprotein(a) concentrations associate with coronary artery disease severity in single-center observational cohort of 238 adultsHigher Lipoprotein(a) Linked to Worse Heart Disease Severity

Study Details

Late-onset rheumatoid arthritis shows higher DAS28 scores and lower remission rates compared to young-onset disease in a meta-analysis

Meta-analysis compares treatment outcomes in older versus younger rheumatoid arthritis patients

Clinical research that matters. Delivered to your inbox.

Lipoprotein(a) concentrations associate with coronary artery disease severity in single-center observational cohort of 238 adultsHigher Lipoprotein(a) Linked to Worse Heart Disease Severity

More on Coronary Artery Disease

Study Details

Late-onset rheumatoid arthritis shows higher DAS28 scores and lower remission rates compared to young-onset disease in a meta-analysis

Meta-analysis compares treatment outcomes in older versus younger rheumatoid arthritis patients

Clinical research that matters. Delivered to your inbox.

Related in Rheumatology

From Other Specialties